DERMATOLOGY Flashcards
Scaly papule that soon forms erythematous plaques covered with a white scale
Psoriasis
Hemorrhagic red papules that do not blanch with pressure
necrotizing vasculitis
Target-shaped lesion that consist in part of erythematous plaques
erythema multiforme
Pseudohyphae and budding yeasts is seen in
Candida infections
“Spaghetti and meatballs” yeast forms are seen in
tinea versicolor
A cytologic technique most often used in the diagnosis of herpesvirus infections (herpes simplex virus or varicella zoster virus)
Tzanck smear
An opaque to transparent, brown-pink “apple jelly” appearance on diascopy
Granulomas
Coral pink color under the wood’s lamp
Erythrasma
A superficial, intertriginous infection caused by Corynebacterium minutissimum
Erythrasma
Pale blue on wood’s lamp
Pseudomonas
Yellow fluorescence on wood’s lamp
Tinea capitis
Caused by dermatophytes (e.g. Micrisporum canis or M. audouinii)
A battery of suspected allergens is applied to the patient’s back under occlusive dressings and allowed to remain in contact with the skin for 48 h
Patch test
Patch test is used to examine evidence of
delayed hypersensitivity reactions
This is the most common type of melanoma
Superficial spreading melanoma
Such lesions usually demonstrate asymmetry, border irregularity, color variegation (black, blue, brown, pink, and white), a diameter >6 mm, and a history of change (e.g., an increase in size or development of associated symptoms such as pruritus or pain).
A flat, colored lesion, <2 cm in diameter, not raised above the surface of the surrounding skin. A “freckle,” or ephelid, is a prototype
Macule
A large (>2 cm) flat lesion with a color different from the surrounding skin
Patch
A small, solid lesion, <0.5 cm in diameter, raised above the surface of the surrounding skin and thus palpable (e.g., a closed comedone, or whitehead, in acne).
Papule
A larger (0.5 to 5.0 cm), firm lesion raised above the surface of the surrounding skin
Nodule
A solid, raised growth >5 cm in diameter.
Tumor
A large (>1 cm), flat-topped, raised lesion; edges may either be distinct (e.g., in psoriasis) or gradually blend with surrounding skin (e.g., in eczematous dermatitis).
Plaque
A small, fluid-filled lesion, <0.5 cm in diameter, raised above the plane of surrounding skin. Fluid is often visible, and the lesions are translucent
Vesicle
A vesicle filled with leukocytes
Pustules
The presence of pustules does not necessarily signify the existence of an infection
A fluid-filled, raised, often translucent lesion >0.5 cm in diameter
Bulla
A raised, erythematous, edematous papule or plaque, usually representing short-lived vasodilation and vasopermeability.
Wheal
A dilated, superficial blood vessel
Telangiectasia
A distinctive thickening of the skin that is characterized by accentuated skin-fold markings.
Lichenification
Excessive accumulation of stratum corneum
Scale
Dried exudate of body fluids that may be either yellow or red
Crust
Loss of epidermis without an associated loss of dermis.
Erosion
Loss of epidermis and at least a portion of the underlying dermis
Ulcer
Linear, angular erosions that may be covered by crust and are caused by scratching.
Excoriation
An acquired loss of substance. In the skin, this may appear as a depression with intact epidermis or as sites of shiny, delicate, wrinkled lesions
Atrophy
A change in the skin secondary to trauma or inflammation. Sites may be erythematous, hypopigmented, or hyperpigmented depending on their age or character. Sites on hair-bearing areas may be characterized by destruction of hair follicles.
Scar
Small, firm, white papules filled with keratin
Milia
Coin-shaped lesion
Nummular
Skin that displays variegated pigmentation, atrophy, and telangiectases.
Poikiloderma
A configuration of skin lesions formed from coalescing rings or incomplete rings
Polycyclic lesions
Erythema with greasy yellow-brown scale
Seborrheic dermatitis
Violaceous flat-topped papules and plaques
Lichen planus
Skin-colored or red-brown macule or papule with dry, rough, adherent scale
Actinic keratosis
Papule with pearly, telangiectatic border on sun- damaged skin
Basal cell carcinoma
Usual site of basal cell carcinoma
Face
Indurated and possibly hyperkeratotic lesions often showing ulceration and/or crusting
Squamous cell carcinoma of the skin
Usual site of squamous cell carcinoma of the skin
Face (especially lower lips, ears)
Brown plaques with adherent, greasy scale; “stuck on” appearance
Seborrheic keratosis
Symmetric erythematous papules and plaques with a collarette of scale
Pityriasis rosea
Most frequent skin reaction to drugs
Morbilliform rash – 91%
Urticaria – 6%
Populations that are at high risk for cutaneous drug reactions (4)
- Elderly
- Autoimmune disease
- Hematopoietic stem cell transplant recipient
- Acute EBV or HIV infection
CD4 count in HIV disease that have 40- to 50-fold increased risk of ADR to sulfamethoxazole and increased risk of severe hypersensitivity reactions
CD4 < 200
Drugs can trigger mediator release either by these 2 mechanism
- Direct mast cell degranulation
2. IgE-specific antibodies
NSAIDs trigger mediator release by
Direct mast cell degranulation
“anaphylactoid” reaction
Radiocontrast media trigger mediator release by
Direct mast cell degranulation
“anaphylactoid” reaction
Penicillin trigger mediator release by
IgE-specific antibodies
Caused by tissue deposition of circulating immune complexes with consumption of complement
Serum sickness
Common cause of serum sickness
Monoclonal antibodies and similar drugs
Symptoms of serum sickness usually develop how many days after drug exposure
6 or more days
Latent period – time needed to synthesize antibody
An important mechanism underlying the most common drug eruptions (morbilliform eruptions)
Delayed hypersensitivity
Genetic determinants may predispose individuals to severe drug reactions by affecting either drug metabolism or immune responses to drugs; most commonly
HLA haptotypes
Drugs that can exacerbate plaque psoriasis (6)
- NSAIDs
- Lithium
- Beta blockers
- TNF antagonists
- Interferon α
- ACE inhibitors
A drug used to treat psoriasis that May induce psoriasis (esp palmoplantar) in patients being treated for other conditions
TNF antagonists